Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Regeneron Pharmaceuticals, Inc. (REGN)

917.33 +98.55 (+12.04%)
As of 2:36:04 PM EDT. Market Open.
Trade REGN on Coinbase
REGN Q3 2026 earnings call
Replay the call for the latest insights.

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
84.30B 65.37B 81.68B 81.12B 59.59B 56.68B
Enterprise Value
79.01B 59.32B 75.78B 75.39B 54.83B 51.04B
Trailing P/E
20.25 -- -- -- -- --
Forward P/E
13.55 13.90 17.95 15.46 14.49 14.36
PEG Ratio (current)
6.55 -- -- -- -- --
Price/Sales
5.64 -- -- -- -- --
Price/Book
2.66 -- -- -- -- --
Enterprise Value/Revenue
5.09 3.98 5.28 5.29 3.86 3.62
Enterprise Value/EBITDA
15.76 11.82 14.86 15.06 11.66 10.62
6/30/2025 - 4/2/1991

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin 27.86%
Operating Margin (ttm) 33.11%

Management Effectiveness

Return on Assets (ttm) 6.53%
Return on Equity (ttm) 14.04%

Income Statement

Revenue (ttm) 15.53B
Revenue Per Share (ttm) 150.31
Quarterly Revenue Growth (yoy) 16.70%
Gross Profit (ttm) 6.91B
EBITDA 4.7B
Net Income Avi to Common (ttm) 4.33B
Diluted EPS (ttm) 40.44
Quarterly Earnings Growth (yoy) -6.80%

Balance Sheet

Total Cash (mrq) 7.99B
Total Cash Per Share (mrq) 80.06
Total Debt (mrq) 2.71B
Total Debt/Equity (mrq) 8.53%
Current Ratio (mrq) 3.34
Book Value Per Share (mrq) 316.11

Cash Flow Statement

Operating Cash Flow (ttm) 4.68B
Levered Free Cash Flow (ttm) 3.07B

Trading Information

Stock Price History

Beta (5Y Monthly) 0.15
52 Week Change 3 25.62%
S&P 500 52-Week Change 3 12.87%
52 Week High 3 935.34
52 Week Low 3 591.52
50-Day Moving Average 3 791.28
200-Day Moving Average 3 736.67

Share Statistics

Avg Vol (3 month) 3 707.2k
Avg Vol (10 day) 3 620.09k
Shares Outstanding 5 101.14M
Implied Shares Outstanding 6 102.95M
Float 8 95.85M
% Held by Insiders 1 2.09%
% Held by Institutions 1 93.18%
Shares Short (10/15/2026) 4 2.13M
Short Ratio (10/15/2026) 4 2.78
Short % of Float (10/15/2026) 4 2.19%
Short % of Shares Outstanding (10/15/2026) 4 2.07%
Shares Short (prior month 9/15/2026) 4 2.53M

Dividends & Splits

Forward Annual Dividend Rate 4 3.76
Forward Annual Dividend Yield 4 0.46%
Trailing Annual Dividend Rate 3 3.64
Trailing Annual Dividend Yield 3 0.44%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 9.00%
Dividend Date 3 8/31/2026
Ex-Dividend Date 4 8/18/2026
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: